Reovirus therapy stimulates endoplasmic reticular stress, NOXA induction, and augments bortezomib-mediated apoptosis in multiple myeloma

Kevin R. Kelly(Keck Hospital of USC), Steffan T. Nawrocki(University of Arizona), Jennifer S. Carew(University of Arizona), Claudia M. Espitia(The University of Texas System), Francis J. Giles(National University of Ireland), Devalingam Mahalingam(The University of Texas at San Antonio Health Science Center), Matt Coffey(Oncolytics Biotech (Canada)), Babatunde O. Oyajobi(The University of Texas at San Antonio Health Science Center)
Oncogene
October 17, 2011
10.1038/onc.2011.478
Cited by 80

Related Papers

Early Results of a Chemoimmunotherapy Regimen of Fludarabine, Cyclophosphamide, and Rituximab As Initial Therapy for Chronic Lymphocytic Leukemia
|Journal of Clinical Oncology|2005|951
Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
|Clinical Cancer Research|2008|782
Results of a randomized study of 3 schedules of low-dose decitabine in higher-risk myelodysplastic syndrome and chronic myelomonocytic leukemia
|Blood|2006|691
Results of intensive chemotherapy in 998 patients age 65 years or older with acute myeloid leukemia or high‐risk myelodysplastic syndrome:
|Cancer|2006|607
Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl–mediated drug resistance
|Blood|2007|485